Related Experiment Video
Updated: Jun 8, 2026
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Retinoblastoma - current treatment and future direction
1Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, United Kingdom. manojparulekar@aol.com
Early Human Development
|October 5, 2010
Summary
Retinoblastoma, a childhood eye cancer, is often curable with early detection and treatment. Lifelong surveillance is crucial for heritable forms due to second cancer risks.
Area of Science:
- Ophthalmology
- Pediatric Oncology
- Genetics
Background:
- Retinoblastoma is the most common primary eye cancer in children.
- It presents in two forms: heritable (a cancer susceptibility syndrome) and non-heritable.
- Early diagnosis and treatment are critical, with high cure rates for intraocular tumors but poor outcomes for extraocular disease.
Purpose of the Study:
- To provide a comprehensive overview of retinoblastoma diagnosis, treatment, and management.
- To highlight the importance of early detection and multidisciplinary care.
- To discuss the implications of heritable retinoblastoma and the need for lifelong surveillance.
Main Methods:
- Diagnosis is primarily clinical; biopsy is contraindicated due to the risk of extraocular spread.
- Treatment involves a multidisciplinary approach including ophthalmic treatment, chemotherapy, radiotherapy, and surgery.
- Screening of family members and lifelong surveillance of mutation carriers are essential.
Main Results:
- Prompt treatment can achieve up to 95% cure rates for intraocular retinoblastoma.
- Extraocular disease is associated with very high mortality.
- Newer treatments like intra-arterial chemotherapy have expanded therapeutic options.
Conclusions:
- Retinoblastoma management requires a multidisciplinary team and tailored treatment strategies.
- Genetic counseling and screening are vital for families affected by heritable retinoblastoma.
- Ongoing surveillance is necessary to monitor for disease recurrence and secondary malignancies.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...